Keyphrases
Androgen Receptor
100%
Metabolic Dysfunction
100%
Dihydrotestosterone
100%
Receptor Mechanisms
100%
Phosphoinositide 3-kinase (PI3K)
57%
Androgens
28%
Insulin Resistance
28%
Insulin Action
28%
Androgen Excess
28%
Biochemical Analysis
14%
Molecular Mechanism
14%
Obesity
14%
Mouse Model
14%
Dissociation
14%
Receptor Binding
14%
Coactivator
14%
Mechanism of Action
14%
Flutamide
14%
Transcriptional Regulation
14%
Histological Analysis
14%
Glucose-insulin System
14%
Consequences of Obesity
14%
Body Mass
14%
Gluconeogenesis
14%
Gonadotropins
14%
Dysregulated
14%
Glucose Metabolism
14%
Kinase Activity
14%
AKT1
14%
Infertility
14%
Specific Mechanisms
14%
Androgen Levels
14%
Serum Androgens
14%
Intolerance
14%
Amenorrhea
14%
Type 2 Diabetes Risk
14%
Impaired Glucose Metabolism
14%
Impaired Glucose Tolerance
14%
Hyperinsulinemia
14%
Corpus Luteum
14%
Glucose Metabolic
14%
Hepatocyte Model
14%
Androgen Effects
14%
Hepatic Insulin Signaling
14%
Gluconeogenic Enzymes
14%
Polycystic Ovary
14%
Hyperandrogenemia
14%
Estrous Cyclicity
14%
P110
14%
Mouse Hepatocytes
14%
Hormonal Assay
14%
Induced Hepatocytes
14%
Reproductive Dysfunction
14%
Metabolic Test
14%
Medicine and Dentistry
Low Drug Dose
100%
Androgen Receptor
100%
Drive
100%
Androstanolone
100%
Receptor Mechanism
100%
Androgen
85%
Phosphoinositide 3-Kinase
57%
Hepatocyte
42%
Glucose Metabolism
28%
Insulin Resistance
28%
Maturity Onset Diabetes of the Young
14%
Gluconeogenesis
14%
Receptor Binding
14%
Amenorrhea
14%
Polycystic Ovary Syndrome
14%
Hyperandrogenism
14%
Impaired Glucose Tolerance
14%
Hyperinsulinemia
14%
Corpus Luteum
14%
Pyruvic Acid
14%
Flutamide
14%
Insulin Signaling
14%
Gonadotropin Release
14%
Biochemistry, Genetics and Molecular Biology
Low Drug Dose
100%
Phosphoinositide 3-Kinase
100%
Drive
100%
Androgen Receptor
100%
Hepatocyte
75%
Mouse
50%
Insulin Resistance
50%
Glucose Metabolism
50%
Enzyme
25%
Receptor Binding
25%
Mouse Model
25%
Gluconeogenesis
25%
Androgen Blood Level
25%
Insulin Signaling
25%
Impaired Glucose Tolerance
25%
Gonadotropin Release
25%
Pharmacology, Toxicology and Pharmaceutical Science
Androgen Receptor
100%
Androstanolone
100%
Androgen
85%
Phosphatidylinositol 3 Kinase
57%
Mouse
28%
Insulin Resistance
28%
Mouse Model
14%
Flutamide
14%
Gonadotropin
14%
Non Insulin Dependent Diabetes Mellitus
14%
Hyperinsulinemia
14%
Hyperandrogenism
14%
Impaired Glucose Tolerance
14%
Amenorrhea
14%
Pyruvic Acid
14%
Ovary Polycystic Disease
14%